HIV/AIDS

April 25, 2024

Traditional healer-initiated HIV testing and care expands in South Africa

Developed in a region with the world’s highest HIV prevalence, this study design and intervention has the potential to impact testing uptake among a “hidden population” by mobilizing trained healers, who vastly outnumber allopathic care providers in South Africa.
From left, Simon Mallal, MBBS, and John Koethe, MD, MSCI. (photo by Susan Urmy)
March 29, 2024

VUMC’s John Koethe named director of the Tennessee Center for AIDS Research

John Koethe, MD, MSCI, associate professor of Medicine in the Division of Infectious Diseases at Vanderbilt University Medical Center, has been appointed director and principal investigator of the Tennessee Center for AIDS Research.

By Bill Snyder
January 11, 2024

Comprehensive Care Clinic’s Ruby Gala set for Feb. 10

The Vanderbilt Comprehensive Care Clinic, Nashville’s original nonprofit medical home for people living with HIV, will hold its annual Ruby Gala on Saturday, Feb. 10, 2024, at Marathon Music Works.

By Bill Snyder
doctors wearing scrubs with red aids awareness ribbons pinned to shirts
December 4, 2023

Report offers a way to overcome the severe lack of HIV providers

In a new report, members of the Southeast AIDS Education and Training Center, which is coordinated by Vanderbilt University Medical Center, offers an innovative approach to increasing the HIV workforce: train all manner of health professionals to care for people with HIV.

By Bill Snyder
October 25, 2023

Immune system’s role in metabolic disease detailed in tissue atlas

Researchers at Vanderbilt University Medical Center have published the largest known single-site adipose tissue atlas — a comprehensive, detailed map of the cells, structures and molecules within a specific tissue or organ, designed to support open-ended study.

By Paul Govern
September 22, 2023

Person named to HIV leadership role

Vanderbilt infectious diseases specialist Anna Person, MD, has been named to a four-year term as vice-chair of the board of the HIV Medicine Association .

By Paul Govern
March 2, 2023

Global study tracks brain infection in people with HIV

A Vanderbilt study is shedding new light on the incidence and mortality of cryptococcal meningitis among people with HIV
By Paul Govern
February 2, 2023

Discovery of “cross-reactive” antibodies could aid treatment of viral co-infections

By Bill Snyder
December 15, 2022

Dooley honored by Treatment Action Group

Vanderbilt's Kelly Dooley, MD, PhD, MPH, recently received the Research in Action Award from the Treatment Action Group (TAG).
By Paul Govern
November 10, 2022

Study explores CVD risk for people with HIV

A Vanderbilt study found that among people with HIV infection, three types of CD4+ T helper cells are associated with incident cardiovascular disease (CVD) that are not explained by CVD risk.
By Matt Batcheldor
September 1, 2022

Study identifies key player in T cell “education”

New Vanderbilt research could inform therapeutic strategies for enhancing thymic function when desired — such as during aging, recovery from radiation therapy or chemotherapy, or other conditions that reduce T cell output.
By Leigh MacMillan
July 7, 2022

Breaking the stigma of AIDS part of Raffanti’s long legacy

On June 29 Stephen Raffanti, MD, MPH, hung up his scrubs at the Vanderbilt Comprehensive Care Clinic for the last time. It was a bittersweet moment for the man who helped lead Nashville out of the darkest days of the AIDS epidemic 30 years ago.
By Bill Snyder
June 8, 2022

Capacity-building grant trains biostatisticians in West Africa

The Vanderbilt Institute for Global Health, Vanderbilt Department of Biostatistics, and Aminu Kano Teaching Hospital (AKTH) have partnered on a new program to train a cohort of highly skilled Nigerian biostatisticians to lead and supervise high-level biostatistics activities for HIV research studies in West Africa. 
By Kristin Centers
1 2 3 … 7